InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.03
(
-0.21%
)
Bitcoin
59,230.42
(
0.19%
)
Post# of 253010
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Thursday, 06/14/2012 8:54:56 AM

Thursday, June 14, 2012 8:54:56 AM

Post# of 253010
Teva's (TEVA +0.4%) Copaxone multiple sclerosis drug performed well vs. a placebo in a Phase III trial that assessed its effectiveness under a new dosage regime of 40mg three times a week rather than the usual 20mg a day schedule
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up